showed that smoking was most likely to be associated with negative progression and adverse outcomes of COVID-19. Moreover, in a systematic review, Vardavas et al. Although most patients have mild symptoms and favorable prognoses, older age is associated with poor prognosis for COVID-19. Many clinical characteristics and outcomes of COVID-19 have been reported.
As of April 7, 2020, there have been 1,279,722 confirmed cases and 72,614 deaths globally. More than 200 countries/territories have reported laboratory-confirmed COVID-19 cases. On March 11, 2020, the WHO announced that COVID-19 had become a global pandemic. The novel coronavirus, which is similar to severe acute respiratory syndrome coronavirus (SARS-CoV), was designated SARS-CoV-2 by the International Committee on Taxonomy of Viruses. The pathogen was quickly identified as a novel coronavirus and the World Health Organization (WHO) officially named the disease Corona Virus Disease 2019 (COVID-19). In December 2019, several cases of unexplained pneumonia with a history of exposure to a South China seafood market were seen in hospitals in Wuhan, Hubei Province, China. Keywords: Charlson comorbidity index, comorbidity, Corona Virus Disease, Elixhauser comorbidity index, length of stay, outcome Introduction The result was similar for the outcome of critical illness (OR 21.333, P = 0.001, 95%CI 3.565-127.672 OR 13.000, P = 0.009, 95%CI 1.921-87.990 OR 11.333, P = 0.008, 95%CI 1.859-69.080, respectively).Ĭonclusions: This study established prognostic scoring models based on comorbidities and clinical information, which may help with the graded management of patients according to prognosis score and remind physicians to pay more attention to patients with high scores. Results: The mean hospital length of stay (LOS) of the COVID-19 patients was 22.82 ± 12.32 days 19 patients (37.3%) were hospitalized for more than 24 days.
The Charlson (CCI), Elixhauser (ECI), and age- and smoking-adjusted Charlson (ASCCI) and Elixhauser (ASECI) comorbidity indices were used to evaluate the patient outcomes. Material and Methods: We retrospectively collected data from 51 patients diagnosed as severe or critical COVID-19 who were admitted between January 29, 2020, and February 18, 2020.
This study established prognostic scoring models based on comorbidities and other clinical information for severe and critical patients with COVID-19. File import instruction Abstractīackground: Corona Virus Disease 2019 (COVID-19) has become a global pandemic.
Select the file that you have just downloaded and select import option Reference Manager (RIS).
#SPSS CODE ELIXHAUSER COMORBID SCORE DOWNLOAD#
Available fromĬlick on Go to download the file. Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices.